These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 29729982)

  • 1. C3 glomerulopathy associated with monoclonal Ig is a distinct subtype.
    Ravindran A; Fervenza FC; Smith RJH; Sethi S
    Kidney Int; 2018 Jul; 94(1):178-186. PubMed ID: 29729982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Both Monoclonal and Polyclonal Immunoglobulin Contingents Mediate Complement Activation in Monoclonal Gammopathy Associated-C3 Glomerulopathy.
    Chauvet S; Roumenina LT; Aucouturier P; Marinozzi MC; Dragon-Durey MA; Karras A; Delmas Y; Le Quintrec M; Guerrot D; Jourde-Chiche N; Ribes D; Ronco P; Bridoux F; Fremeaux-Bacchi V
    Front Immunol; 2018; 9():2260. PubMed ID: 30333829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C3 glomerulopathy associated with monoclonal gammopathy: impact of chronic histologic lesions and beneficial effects of clone-targeted therapies.
    Caravaca-Fontán F; Lucientes L; Serra N; Cavero T; Rodado R; Ramos N; Gonzalez F; Shabaka A; Cabello V; Huerta A; Pampa-Saico S; Gutiérrez E; Quintana LF; López-Rubio ME; Draibe J; Alonso Titos J; Fernández-Juárez G; Goicoechea de Jorge E; Praga M
    Nephrol Dial Transplant; 2022 Oct; 37(11):2128-2137. PubMed ID: 34677610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of membranoproliferative glomerulonephritis and C3-glomerulopathy in children and adolescents.
    Holle J; Berenberg-Goßler L; Wu K; Beringer O; Kropp F; Müller D; Thumfart J
    Pediatr Nephrol; 2018 Dec; 33(12):2289-2298. PubMed ID: 30238151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C3 glomerulonephritis with a severe crescentic phenotype.
    Ravindran A; Fervenza FC; Smith RJH; Sethi S
    Pediatr Nephrol; 2017 Sep; 32(9):1625-1633. PubMed ID: 28593446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C3 Glomerulopathy: Ten Years' Experience at Mayo Clinic.
    Ravindran A; Fervenza FC; Smith RJH; De Vriese AS; Sethi S
    Mayo Clin Proc; 2018 Aug; 93(8):991-1008. PubMed ID: 30077216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of B-cell disorder improves renal outcome of patients with monoclonal gammopathy-associated C3 glomerulopathy.
    Chauvet S; Frémeaux-Bacchi V; Petitprez F; Karras A; Daniel L; Burtey S; Choukroun G; Delmas Y; Guerrot D; François A; Le Quintrec M; Javaugue V; Ribes D; Vrigneaud L; Arnulf B; Goujon JM; Ronco P; Touchard G; Bridoux F
    Blood; 2017 Mar; 129(11):1437-1447. PubMed ID: 28069603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glomerulonephritis with isolated C3 deposits and monoclonal gammopathy: a fortuitous association?
    Bridoux F; Desport E; Frémeaux-Bacchi V; Chong CF; Gombert JM; Lacombe C; Quellard N; Touchard G
    Clin J Am Soc Nephrol; 2011 Sep; 6(9):2165-74. PubMed ID: 21784830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological features of C3 glomerulopathy in children: a single-center experience.
    Drake KA; Ellington N; Gattineni J; Torrealba JR; Hendricks AR
    Pediatr Nephrol; 2020 Jan; 35(1):153-162. PubMed ID: 31667615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferative glomerulonephritis with monoclonal IgG deposits.
    Nasr SH; Satoskar A; Markowitz GS; Valeri AM; Appel GB; Stokes MB; Nadasdy T; D'Agati VD
    J Am Soc Nephrol; 2009 Sep; 20(9):2055-64. PubMed ID: 19470674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy.
    Bomback AS; Santoriello D; Avasare RS; Regunathan-Shenk R; Canetta PA; Ahn W; Radhakrishnan J; Marasa M; Rosenstiel PE; Herlitz LC; Markowitz GS; D'Agati VD; Appel GB
    Kidney Int; 2018 Apr; 93(4):977-985. PubMed ID: 29310824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C3 glomerulonephritis associated with monoclonal gammopathy: a case series.
    Zand L; Kattah A; Fervenza FC; Smith RJ; Nasr SH; Zhang Y; Vrana JA; Leung N; Cornell LD; Sethi S
    Am J Kidney Dis; 2013 Sep; 62(3):506-14. PubMed ID: 23623956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferative glomerulonephritis with monoclonal IgG deposits: a distinct entity mimicking immune-complex glomerulonephritis.
    Nasr SH; Markowitz GS; Stokes MB; Seshan SV; Valderrama E; Appel GB; Aucouturier P; D'Agati VD
    Kidney Int; 2004 Jan; 65(1):85-96. PubMed ID: 14675039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C3 Glomerulopathy and post-infectious glomerulonephritis define a disease spectrum.
    Al-Ghaithi B; Chanchlani R; Riedl M; Thorner P; Licht C
    Pediatr Nephrol; 2016 Nov; 31(11):2079-86. PubMed ID: 27008643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete biopsy-proven resolution of deposits in recurrent proliferative glomerulonephritis with monoclonal IgG deposits (PGNMIGD) following rituximab treatment in renal allograft.
    Von Visger J; Cassol C; Nori U; Franco-Ahumada G; Nadasdy T; Satoskar AA
    BMC Nephrol; 2019 Feb; 20(1):53. PubMed ID: 30764798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies.
    Servais A; Noël LH; Roumenina LT; Le Quintrec M; Ngo S; Dragon-Durey MA; Macher MA; Zuber J; Karras A; Provot F; Moulin B; Grünfeld JP; Niaudet P; Lesavre P; Frémeaux-Bacchi V
    Kidney Int; 2012 Aug; 82(4):454-64. PubMed ID: 22456601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C3 glomerulopathy and current dilemmas.
    Ito N; Ohashi R; Nagata M
    Clin Exp Nephrol; 2017 Aug; 21(4):541-551. PubMed ID: 27878657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C4 Nephritic Factors in C3 Glomerulopathy: A Case Series.
    Zhang Y; Meyer NC; Fervenza FC; Lau W; Keenan A; Cara-Fuentes G; Shao D; Akber A; Fremeaux-Bacchi V; Sethi S; Nester CM; Smith RJH
    Am J Kidney Dis; 2017 Dec; 70(6):834-843. PubMed ID: 28838767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal immunoglobulin mediates complement activation in monoclonal gammopathy associated-C3 glomerulonephritis.
    Li LL; Li ZY; Wang SX; Yu XJ; Tan Y; Wang Y; Yu F; Zhao MH
    BMC Nephrol; 2019 Dec; 20(1):459. PubMed ID: 31823738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. von Willebrand factor variants in C3 glomerulopathy: A Chinese cohort study.
    Chen YY; Han SS; Cao Y; Yu XJ; Zhu L; Luo JC; Song WC; Yu F; Mao YH; Zhao MH
    Clin Immunol; 2021 Aug; 229():108794. PubMed ID: 34245915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.